Literature DB >> 10625692

The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo.

Y Shen1, P Lyons, M Cooley, D Davidson, A Veillette, R Salgia, J D Griffin, M D Schaller.   

Abstract

The noncatalytic domain of protein-tyrosine phosphatase (PTP)-PEST contains a binding site for the focal adhesion-associated protein paxillin. This binding site has been narrowed to a 52-residue sequence that is composed of two nonoverlapping, weak paxillin binding sites. The PTP-PEST binding site on paxillin has been mapped to the two carboxyl-terminal LIM (lin11, isl-1, and mec-3) domains. Transient expression of PTP-PEST reduced tyrosine phosphorylation of p130(cas), as anticipated. A PTP-PEST mutant defective for binding p130(cas) does not cause a reduction in its tyrosine phosphorylation in vivo. Expression of PTP-PEST also caused a reduction of phosphotyrosine on paxillin. Expression of mutants of PTP-PEST with deletions in the paxillin-binding site did not associate with paxillin in vivo and failed to cause a reduction in the phosphotyrosine content of paxillin. These results demonstrate that paxillin can serve as a PTP-PEST substrate in vivo and support the model that a noncatalytic domain interaction recruits paxillin to PTP-PEST to facilitate its dephosphorylation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10625692     DOI: 10.1074/jbc.275.2.1405

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance.

Authors:  Elena V Tibaldi; Ravi Salgia; Ellis L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 2.  Central role of paxillin phosphorylation in regulation of LFA-1 integrins activity and lymphocyte migration.

Authors:  Larisa Y Romanova; J Frederic Mushinski
Journal:  Cell Adh Migr       Date:  2011 Nov-Dec       Impact factor: 3.405

3.  TCR-induced downregulation of protein tyrosine phosphatase PEST augments secondary T cell responses.

Authors:  Yutaka Arimura; Torkel Vang; Lutz Tautz; Scott Williams; Tomas Mustelin
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

Review 4.  Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis.

Authors:  Haein Park; Dan Ishihara; Dianne Cox
Journal:  Arch Biochem Biophys       Date:  2011-02-26       Impact factor: 4.013

5.  Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness.

Authors:  Michael C Brown; Leslie A Cary; Jennifer S Jamieson; Jonathan A Cooper; Christopher E Turner
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

6.  A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells.

Authors:  Silvia M Goicoechea; Ashtyn Zinn; Sahezeel S Awadia; Kyle Snyder; Rafael Garcia-Mata
Journal:  J Cell Sci       Date:  2017-02-15       Impact factor: 5.285

7.  Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy.

Authors:  Elizabeth A Grace; Jorge Busciglio
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 8.  Role of dynamin 2 in the disassembly of focal adhesions.

Authors:  Laura Briñas; Stéphane Vassilopoulos; Gisèle Bonne; Pascale Guicheney; Marc Bitoun
Journal:  J Mol Med (Berl)       Date:  2013-04-23       Impact factor: 4.599

Review 9.  Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.

Authors:  Stephanie M Stanford; Novella Rapini; Nunzio Bottini
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

10.  PPM1F controls integrin activity via a conserved phospho-switch.

Authors:  Tanja M Grimm; Nina I Dierdorf; Karin Betz; Christoph Paone; Christof R Hauck
Journal:  J Cell Biol       Date:  2020-12-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.